Based on a reanalytical methodology by bioinformatics that utilizes a previously published transcriptomic public dataset in pulmonary tuberculosis, we succeeded in validating a total of three candidates, CARD17, GBP2, and C1QB genes, in clinical specimens. The gene discussed is C1QB; the disease is pulmonary tuberculosis.